Hasani N, Ebrahimi M, Ghasemi-Panahi B, HosseinKhani A
Similarly to other injections, it was prescribed to treat Type 2 Diabetes, but in December 2024 was approved to treat obesity on the NHS.[5] Potential Side Effects and Risks Although GLP-1 drugs for diabetes and weight loss have proven to be effective, they do have side effects and the most common are: [3] Nausea and vomiting Constipation Diarrhoea Fatigue Indigestion Risk of low or high blood sugar Because GLP-1 receptor agonists mimic a natural gut hormone, the most common side effects are gastrointestinal including nausea, vomiting, diarrhoea, and a feeling of early fullness
It is available through compounding pharmacies for investigational and clinical off-label use, but it should only be sourced through a licensed, reputable compounding pharmacy under physician oversight
However, accessibility, affordability, physician supervision, and long-term monitoring remain important considerations for widespread clinical adoption
99281 covers minor problems
Indigenous Services Canada coverage varies by region and specific health transfer agreements